These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 11015550)

  • 1. Late-onset neutropenia in very low birth weight infants.
    Omar SA; Salhadar A; Wooliever DE; Alsgaard PK
    Pediatrics; 2000 Oct; 106(4):E55. PubMed ID: 11015550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late-onset neutropenia: defining limits of neutrophil count in very low birth weight infants.
    Vetter-Laracy S; Balliu PR; Salinas JA; Duran MA
    J Perinatol; 2014 Jan; 34(1):22-6. PubMed ID: 24030676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late-onset neutropenia in very low birthweight infants.
    Chirico G; Motta M; Villani P; Cavazza A; Cardone ML
    Acta Paediatr Suppl; 2002; 91(438):104-8. PubMed ID: 12477272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early neutropenia is not associated with an increased rate of nosocomial infection in very low-birth-weight infants.
    Teng RJ; Wu TJ; Garrison RD; Sharma R; Hudak ML
    J Perinatol; 2009 Mar; 29(3):219-24. PubMed ID: 19078971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can neutrophil responses in very low birth weight infants predict the organisms responsible for late-onset bacterial or fungal sepsis?
    Sarkar S; Bhagat I; Hieber S; Donn SM
    J Perinatol; 2006 Aug; 26(8):501-5. PubMed ID: 16761008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo effect of recombinant human granulocyte colony-stimulating factor on phagocytic function and oxidative burst activity in septic neutropenic neonates.
    Ahmad M; Fleit HB; Golightly MG; La Gamma EF
    Biol Neonate; 2004; 86(1):48-54. PubMed ID: 15057022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial of granulocyte-macrophage colony-stimulating factor in neonates with sepsis and neutropenia.
    Bilgin K; Yaramiş A; Haspolat K; Taş MA; Günbey S; Derman O
    Pediatrics; 2001 Jan; 107(1):36-41. PubMed ID: 11134431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal neutropenia: what diagnostic evaluation is needed and when is treatment recommended?
    Del Vecchio A; Christensen RD
    Early Hum Dev; 2012 May; 88 Suppl 2():S19-24. PubMed ID: 22633505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of extremely low birth weight infants with leukemoid reaction.
    Hsiao R; Omar SA
    Pediatrics; 2005 Jul; 116(1):e43-51. PubMed ID: 15930185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased incidence of sepsis at birth in neutropenic infants of mothers with preeclampsia.
    Doron MW; Makhlouf RA; Katz VL; Lawson EE; Stiles AD
    J Pediatr; 1994 Sep; 125(3):452-8. PubMed ID: 8071757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human granulocyte colony-stimulating factor may improve outcome attributable to neonatal sepsis complicated by neutropenia.
    Kocherlakota P; La Gamma EF
    Pediatrics; 1997 Jul; 100(1):E6. PubMed ID: 9200380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, placebo-controlled trial of granulocyte colony-stimulating factor administration to newborn infants with neutropenia and clinical signs of early-onset sepsis.
    Schibler KR; Osborne KA; Leung LY; Le TV; Baker SI; Thompson DD
    Pediatrics; 1998 Jul; 102(1 Pt 1):6-13. PubMed ID: 9651406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Risk factors for neutropenia of late newborns].
    Li L; Yang B; Gao XY; Ren Y; Su M; Yang CY; Huang D; Wang HY
    Zhongguo Dang Dai Er Ke Za Zhi; 2021 Apr; 23(4):375-380. PubMed ID: 33840410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary report: rhG-CSF may reduce the incidence of neonatal sepsis in prolonged preeclampsia-associated neutropenia.
    Kocherlakota P; La Gamma EF
    Pediatrics; 1998 Nov; 102(5):1107-11. PubMed ID: 9794941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of recombinant human granulocyte colony stimulating factor in very-low-birth-weight infants with early neutropenia.
    Teng RJ; Wu TJ; Sharma R; Garrison RD; Hudak ML
    J Formos Med Assoc; 2015 Feb; 114(2):174-9. PubMed ID: 25678180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between two and five doses a week of recombinant human erythropoietin for anemia of prematurity: a randomized trial.
    Brown MS; Keith JF
    Pediatrics; 1999 Aug; 104(2 Pt 1):210-5. PubMed ID: 10428996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth, efficacy, and safety of feeding an iron-fortified human milk fortifier.
    Berseth CL; Van Aerde JE; Gross S; Stolz SI; Harris CL; Hansen JW
    Pediatrics; 2004 Dec; 114(6):e699-706. PubMed ID: 15545616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human erythropoietin in the treatment of anemia of prematurity.
    Chen JY; Wu TS; Chanlai SP
    Am J Perinatol; 1995 Sep; 12(5):314-8. PubMed ID: 8540930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preeclampsia does not increase the risk for culture proven sepsis in very low birth weight infants.
    Paul DA; Leef KH; Sciscione A; Tuttle DJ; Stefano JL
    Am J Perinatol; 1999; 16(7):365-72. PubMed ID: 10614705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency, natural course, and outcome of neonatal neutropenia.
    Funke A; Berner R; Traichel B; Schmeisser D; Leititis JU; Niemeyer CM
    Pediatrics; 2000 Jul; 106(1 Pt 1):45-51. PubMed ID: 10878148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.